Related Experiment Video
Updated: Sep 6, 2025

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
Low levels of cadmium exposure affect bone by inhibiting Lgr4 expression in osteoblasts and osteoclasts
Miaomiao Wang1, Jingjing Liu1, Guoying Zhu2
1Department of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.
Background:
Cadmium exposure is associated with bone loss. However, the mechanisms involved have not yet been fully understood. Leucine-rich repeat containing GPCR-4 (LGR4) can bind with the receptor activator of nuclear factors κB ligand (RANKL) and inhibit osteoclast formation. In addition, Lgr4 plays an important role in maintaining osteoblast activity. In the present study the effect of cadmium exposure on bone was investigated in terms of Lgr4 expression.
Methods:
Raw 264.7 cells and primary osteoblasts were exposed to cadmium (0-60 nM/L). The effects of cadmium on osteoclast formation and osteoblast activity were investigated. Osteoclast differentiation-related (Traf6, NFATc1) and osteoblast-related (RANKL; osteoprotegerin, OPG) gene and protein expression were determined. Lgr4 expression in osteoclasts and osteoblasts were also determined. A rat model was established to show the effects of cadmium (50 mg/L) on bone loss and Lgr4 expression in vivo.
Results:
Cadmium exposure inhibited osteoblast activities and stimulated osteoclast formation. Cadmium exposure also inhibited Lgr4 expression in both osteoclasts and osteoblasts. Low dose of RANKL added to the culture medium could promote osteoclast formation in cadmium-pretreated RAW264.7 cells. Blocking Lgr4 in osteoclasts only slightly inhibited cadmium-induced osteoclast formation in cadmium-pretreated RAW264.7 cells. Cadmium significantly upregulated the AKT/ERK signaling pathway. An in vivo study showed that cadmium exposure promoted osteoclast formation and inhibited Lgr4 expression.
Conclusions:
Our data indicates that cadmium may induce bone loss by inhibiting Lgr4-related bone formation and promoting Lgr4-related osteoclast formation.
Insights
Cadmium exposure harms bone by reducing Leucine-rich repeat containing GPCR-4 (LGR4) expression, which impairs bone formation and boosts osteoclast activity. This study clarifies cadmium
Area of Science:
- Environmental toxicology
- Bone biology
- Cell signaling
Background:
- Cadmium exposure is linked to bone loss, but mechanisms are unclear.
- Leucine-rich repeat containing GPCR-4 (LGR4) regulates osteoclast formation and osteoblast activity.
- Investigating LGR4's role in cadmium-induced bone loss is crucial.
Purpose of the Study:
- To examine the effect of cadmium exposure on bone.
- To investigate the role of LGR4 expression in cadmium-induced bone loss.
- To elucidate the molecular mechanisms underlying cadmium's impact on bone metabolism.
Main Methods:
- In vitro exposure of cells (RAW 264.7, primary osteoblasts) to cadmium.
- Assessment of osteoclast formation and osteoblast activity.
- Analysis of gene/protein expression (LGR4, RANKL, OPG, Traf6, NFATc1, AKT/ERK signaling) and in vivo rat model.
Main Results:
- Cadmium inhibited osteoblast activity and promoted osteoclast formation.
- Cadmium exposure decreased LGR4 expression in both cell types.
- Cadmium upregulated AKT/ERK signaling; in vivo studies confirmed bone loss and reduced LGR4 expression.
Conclusions:
- Cadmium induces bone loss by suppressing LGR4-mediated bone formation.
- Cadmium promotes LGR4-related osteoclast formation, contributing to bone resorption.
- LGR4 signaling is a key pathway affected by cadmium toxicity in bone.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Skeleton and Calcium Homeostasis
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...

